Compare Novartis AG (NVS) vs Direxion Daily TSLA Bull 2X Shares (TSLL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Direxion Daily TSLA Bull 2X Shares — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Direxion Daily TSLA Bull 2X Shares trades at $11.27. The key difference: Novartis AG pays a 3.17% dividend while Direxion Daily TSLA Bull 2X Shares pays none, and Novartis AG is trading nearer its 52-week high, Direxion Daily TSLA Bull 2X Shares nearer its low. Which is the better fit depends on your goals.
| NVS | TSLL | |
|---|---|---|
Market Cap | $290.25B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $168.62 | $23.03 |
52-Week Low | $113.50 | $10.29 |
Enterprise Value | $330.27B | — |
Dividend Yield | 3.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Direxion Daily TSLA Bull 2X Shares
TSLL provides 200% of the daily performance of Tesla, Inc. (TSLA). It uses swaps and financial derivatives to achieve its 2x leverage, making it a high-volatility tool for tactical trading rather than long-term investment due to daily resets.
Read more on TSLL →
